+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cancer Biological Therapy Market Research Report by Product (Cancer Growth Blockers, Monoclonal Antibodies, and Vaccines), Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 245 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5336922
UP TO OFF until Dec 31st 2022
The Global Cancer Biological Therapy Market size was estimated at USD 52.35 billion in 2021, USD 58.28 billion in 2022, and is projected to grow at a CAGR 11.49% to reach USD 100.58 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cancer Biological Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Cancer Growth Blockers, Monoclonal Antibodies, and Vaccines.
  • Based on Distribution Channel, the market was studied across Hospital and Retail & Mail Order Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cancer Biological Therapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cancer Biological Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cancer Biological Therapy Market, including AbbVie, Inc, Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb, Celgene Corporation, Eisai Co., Ltd., Eli Lilly and Company, EnGeneIC Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Incyte Corp, Johnson & Johnson Services, Inc,, Merck & Co., Inc., Novartis International AG, Otsuka Pharmaceutical Co., Ltd, Pfizer, Inc, Sanofi SA, Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cancer Biological Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cancer Biological Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cancer Biological Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Cancer Biological Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Cancer Biological Therapy Market?
6. What is the market share of the leading vendors in the Global Cancer Biological Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Cancer Biological Therapy Market?
Frequently Asked Questions about the Global Cancer Biological Therapy Market

What is the estimated value of the Global Cancer Biological Therapy Market?

The Global Cancer Biological Therapy Market was estimated to be valued at $52.35 Billion in 2021.

What is the growth rate of the Global Cancer Biological Therapy Market?

The growth rate of the Global Cancer Biological Therapy Market is 11.4%, with an estimated value of $100.58 Billion by 2027.

What is the forecasted size of the Global Cancer Biological Therapy Market?

The Global Cancer Biological Therapy Market is estimated to be worth $100.58 Billion by 2027.

Who are the key companies in the Global Cancer Biological Therapy Market?

Key companies in the Global Cancer Biological Therapy Market include AbbVie, Inc, Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bayer AG, Bristol, Myers Squibb and Eisai Co., Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cancer demands cancer biological therapy
5.1.1.2. Rising awareness on cancer coupled with increased healthcare expenditure
5.1.1.3. Increasing elderly population and risk of cancer globally
5.1.2. Restraints
5.1.2.1. Unaffordability due to capital intensive treatment
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements in cancer biologics
5.1.3.2. Rising research and development activities coupled with favorable government policies
5.1.4. Challenges
5.1.4.1. Probable effects of anti-cancer drug therapy
5.2. Cumulative Impact of COVID-19
6. Cancer Biological Therapy Market, by Product
6.1. Introduction
6.2. Cancer Growth Blockers
6.3. Monoclonal Antibodies
6.4. Vaccines
7. Cancer Biological Therapy Market, by Distribution Channel
7.1. Introduction
7.2. Hospital
7.3. Retail & Mail Order Pharmacies
8. Americas Cancer Biological Therapy Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cancer Biological Therapy Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Cancer Biological Therapy Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie, Inc
12.2. Amgen Inc.
12.3. Astellas Pharma Inc.
12.4. AstraZeneca PLC
12.5. Bausch Health Companies Inc.
12.6. Bayer AG
12.7. Bristol-Myers Squibb
12.8. Celgene Corporation
12.9. Eisai Co., Ltd.
12.10. Eli Lilly and Company
12.11. EnGeneIC Ltd
12.12. F. Hoffmann-La Roche AG
12.13. GlaxoSmithKline PLC
12.14. Hikma Pharmaceuticals PLC
12.15. Incyte Corp
12.16. Johnson & Johnson Services, Inc,
12.17. Merck & Co., Inc.
12.18. Novartis International AG
12.19. Otsuka Pharmaceutical Co., Ltd
12.20. Pfizer, Inc
12.21. Sanofi SA
12.22. Spectrum Pharmaceuticals, Inc.
12.23. Takeda Pharmaceutical Company Limited
12.24. Teva Pharmaceutical Industries Ltd
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL CANCER BIOLOGICAL THERAPY MARKET DYNAMICS
FIGURE 8. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 18. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 20. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 25. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 26. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 28. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 30. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 31. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 32. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 34. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2027
FIGURE 36. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 40. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 55. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 67. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 30. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 36. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 37. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 38. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 39. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 40. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 41. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 42. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 43. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 44. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 45. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 46. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 47. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 48. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 49. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 50. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 51. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 52. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 55. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 56. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 57. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 58. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 59. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 60. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 61. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 62. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 63. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 64. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 65. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 67. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 68. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 70. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 71. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 73. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 74. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 76. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 77. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 79. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 80. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 82. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 83. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 85. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 86. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 88. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 93. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 95. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 96. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 98. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 99. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 101. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 102. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 104. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 105. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 107. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 108. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 109. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 110. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 111. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 113. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 114. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 115. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 116. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 117. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 118. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 119. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 120. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 121. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 122. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 123. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 125. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 126. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 127. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 128. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 129. GLOBAL CANCER BIOLOGICAL THERAPY MARKET RANKING
TABLE 130. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 131. GLOBAL CANCER BIOLOGICAL THERAPY MARKET MERGER & ACQUISITION
TABLE 132. GLOBAL CANCER BIOLOGICAL THERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 133. GLOBAL CANCER BIOLOGICAL THERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 134. GLOBAL CANCER BIOLOGICAL THERAPY MARKET INVESTMENT & FUNDING
TABLE 135. GLOBAL CANCER BIOLOGICAL THERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 136. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie, Inc
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • EnGeneIC Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Incyte Corp
  • Johnson & Johnson Services, Inc,
  • Merck & Co., Inc.
  • Novartis International AG
  • Otsuka Pharmaceutical Co., Ltd
  • Pfizer, Inc
  • Sanofi SA
  • Spectrum Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...